CLO21-018: Clinical Characteristics of Breast Cancer Patients Treated With Trastuzumab-anns, a Trastuzumab Biosimilar, in a Real-World Setting

View More View Less
  • 1 Amgen Inc., Thousand Oaks, CA
  • | 2 University of Miami, Coral Gables, FL
Restricted access

Corresponding Author: Ran Jin, PhD
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 178 178 18
PDF Downloads 284 284 11
EPUB Downloads 0 0 0